Marshall Wace
ZY

Marshall Wace’s Zymergen Inc. Common Stock ZY Stock Holding History

Marshall Wace’s Portfolio ZY Stock Details ZY Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2022
Q3 		– Sell
-181,580
Closed -$223K – 3995
2022
Q2 		$223K Buy
+181,580
New +$304K ﹤0.01% 3137

Other funds holding ZY

SIAU
SB Investment Advisers (UK) London, United Kingdom $7.66B AUM 20.12% 1-Year Est. Return
AIM
ARK Investment Management St. Petersburg, Florida $15.4B AUM 50.29% 1-Year Est. Return
Morgan Stanley
Morgan Stanley New York $1.89T AUM 35.08% 1-Year Est. Return
TVPI
True Venture Partners IV Palo Alto, California $8.41M AUM 78.89% 1-Year Est. Return
Baillie Gifford & Co
Baillie Gifford & Co Edinburgh, United Kingdom $110B AUM 4.8% 1-Year Est. Return
DCI
Data Collective II Palo Alto, California $8.44M AUM 11.7% 1-Year Est. Return
Vanguard Group
Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return
E
Ergoteles New York $68.2M AUM 36.16% 1-Year Est. Return
BlackRock
BlackRock New York $6.73T AUM 46.02% 1-Year Est. Return
CFM
Comprehensive Financial Management Los Gatos, California $3.05B AUM 1.77% 1-Year Est. Return

Marshall Wace's ZY Position: Q3 2022 in Review

Marshall Wace sold out of Zymergen Inc. Common Stock (ZY) in Q3 2022, closing a stake of 181,580 shares — an estimated $223K sold.

Marshall Wace first reported a position in ZY in Q2 2022 and held it in 1 quarter. The position peaked at $223K in Q2 2022. 86 funds tracked by Wall St. Rank hold ZY as of Q3 2022.

  • Marshall Wace reported no remaining Zymergen Inc. Common Stock position as of Q3 2022 after selling out during the quarter.
  • Marshall Wace sold 181,580 Zymergen Inc. Common Stock shares in Q3 2022, an estimated $223K.
  • Marshall Wace first reported a position in Zymergen Inc. Common Stock in Q2 2022 and held it in 1 quarter.
  • Marshall Wace's Zymergen Inc. Common Stock position peaked at $223K in Q2 2022.
  • 86 funds tracked by Wall St. Rank held Zymergen Inc. Common Stock as of Q3 2022.

Based on Marshall Wace's 13F filing for Q3 2022, filed 14 Nov 2022.